Why the study?
Does the ALDH2-deficient genotype increase the risk of poor coronary collateral circulation in patients with chronic ischemia?
Does the ALDH2-deficient genotype increase the risk of poor coronary collateral circulation in patients with chronic ischemia?
ALDH2 deficiency is associated with poor coronary collateral circulation in chronic ischemia, suggesting genotype-guided therapeutic individualization may be beneficial, particularly in East Asian populations.
Answers are grounded in this paper and cite their sources.
ALDH2-deficient genotype was associated with poor CCC; leaves open whether genotype informs risk stratification in chronic ischemia.
This study demonstrated that ALDH2 possesses an intrinsic capacity to regulate angiogenesis via hypoxia-inducible factor-1α and vascular endothelial growth factor. Patients with ALDH2-deficient genotype displayed a higher risk of developing poor CCC. Therapeutic individualization based on ALDH2 allele distribution may thus improve the therapeutic benefit, especially in the East Asian decedents.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: